BenzingaOctober 6, 2026 at 3:58 AM NY21 Days Ago
Regeneron Pharmaceuticals, Sanofi Amend License, Collaboration Agreement To Jointly Develop, Commercialize Four New Regeneron-Invented Antibodies; Regeneron Anticipates Pre-Tax Acquired In-Process Research And Development Charge Of ~$22M
https://www.sec.gov/ix?doc=/Archives/edgar/data/872589/000110465926113895/tm2627077d1_8k.htm
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
